Log In
BCIQ
Print this Print this
 

modafinil/flecainide (THN102)

  Manage Alerts
Collapse Summary General Information
Company Theranexus
DescriptionCombination of wakefulness drug modafinil, a neural activity modulator, and low-dose flecainide, a glial connexin modulator
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationExcessive sleepiness
Indication DetailsTreat narcolepsy
Regulatory Designation U.S. - Orphan Drug (Treat narcolepsy)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today